DrugMatrix assay for Adrenergic beta3 radioligand binding ([125I] Cyanopindolol) targets a single homologous protein. The cell type used in the assay is HEK293, the subcellular fraction is Membrane, and it is an In vitro binding assay. Is the molecule assay-effective?